EVGN
Evogene Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.54
−1.30%Margins
Gross margin
-123.9%
EBITDA margin
-961.4%
EBIT margin
-1035.0%
Net margin
-694.2%
FCF margin
-884.8%
275.8%
Return on equity
-67.5%
Return on assets
1137.7%
Return on invested capital
0.08x
Asset turnover
-$11.5M
Cash from operations
$0.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026